| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | Apr 11, 2024 | Option Exercise | $0.54 | 5,017 | 2,709 | 60,648 | Apr 15, 2024, 04:24 PM | |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | Apr 12, 2024 | Option Exercise | $1.08 | 6,349 | 6,857 | 66,997 | Apr 15, 2024, 04:24 PM | |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | Mar 11, 2024 | Option Exercise | $0.54 | 5,017 | 2,709 | 49,283 | Mar 13, 2024, 05:35 PM | |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | Mar 12, 2024 | Option Exercise | $1.08 | 6,348 | 6,856 | 55,631 | Mar 13, 2024, 05:35 PM | |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | Feb 12, 2024 | Option Exercise | $0.84 | 11,366 | 9,566 | 44,266 | Feb 13, 2024, 04:08 PM | |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | Jan 11, 2024 | Option Exercise | $0.54 | 5,017 | 2,709 | 26,552 | Jan 12, 2024, 04:01 PM | |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | Jan 12, 2024 | Option Exercise | $1.08 | 6,348 | 6,856 | 32,900 | Jan 12, 2024, 04:01 PM | |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | Dec 11, 2023 | Option Exercise | $0.54 | 5,018 | 2,710 | 20,069 | Dec 12, 2023, 05:08 PM | |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | Nov 13, 2023 | Option Exercise | $0.54 | 5,017 | 2,709 | 15,051 | Nov 14, 2023, 06:18 PM | |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | Nov 03, 2023 | Option Exercise | $0.54 | 10,034 | 5,418 | 10,034 | Nov 07, 2023, 05:15 PM | |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | Aug 10, 2023 | Sale | $6.85 | 149,250 | 1,022,362 | 74,625 | Aug 11, 2023, 07:11 PM | |
| MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Officer | Aug 11, 2023 | Sale | $6.81 | 314,182 | 2,138,303 | 80,909 | Aug 11, 2023, 07:11 PM | |
| NVLS | Nivalis Therapeutics, Inc. | Rodman David Malcom | Exec Vice President and CMO | Jan 04, 2017 | Sale | $2.27 | 6,687 | 15,179 | 11,368 | Jan 05, 2017, 11:00 AM | |
| NVLS | Nivalis Therapeutics, Inc. | Rodman David Malcom | Exec Vice President and CMO | Oct 04, 2016 | Sale | $7.96 | 5,820 | 46,327 | 12,236 | Oct 05, 2016, 04:16 PM | |
| NVLS | Nivalis Therapeutics, Inc. | Rodman David Malcom | Exec Vice President and CMO | Jul 05, 2016 | Sale | $4.66 | 5,950 | 27,727 | 12,105 | Jul 06, 2016, 04:15 PM |
Menu